BRF reported a net income of BRL 1.14 billion (US$200 million) in Q3 2024, a major turnaround from the loss of BRL 262 million in Q3 2023. BRF Pet SA achieved significant growth in the super-premium natural pet food segment, supported by operational efficiency in logistics and inventory. A major milestone was the FDA approval for its Bastos plant, enabling wet pet food exports to the U.S., aligning with its international growth strategy. Product innovations like Biofresh for Dogs Loin and Pineapple and successful campaigns by Guabi Natural and Gran Plus further bolstered the pet division’s performance. Strategic grain arbitrage operations also contributed to improved financial outcomes.
Advertisement
